On the public citation graph

Discovery and Mechanistic Insights into Thieno[3,2-D]Pyrimidine and Heterocyclic Fused Pyrimidines Inhibitors Targeting Tubulin for Cancer Therapy

0 signed · 27 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/anie.202100273openalex-extracted

Comprehensive Analysis of Binding Sites in Tubulin

inferredcites →https://doi.org/10.1002/cmdc.201100361openalex-extracted

The Tubulin Colchicine Domain: a Molecular Modeling Perspective

inferredcites →https://doi.org/10.1002/cmdc.201300531openalex-extracted

Effects of the Tumor‐Vasculature‐Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels

inferredcites →https://doi.org/10.1016/j.bmcl.2010.01.155openalex-extracted

Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure–activity relationship of the quinazoline ring

inferredcites →https://doi.org/10.1016/j.drup.2020.100742openalex-extracted

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

inferredcites →https://doi.org/10.1016/j.drup.2022.100881openalex-extracted

Paclitaxel resistance related to nuclear envelope structural sturdiness

inferredcites →https://doi.org/10.1016/j.ejmech.2018.04.011openalex-extracted

Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site

inferredcites →https://doi.org/10.1016/j.ejmech.2022.115085openalex-extracted

Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors

inferredcites →https://doi.org/10.1016/j.ejmech.2023.115470openalex-extracted

Discovery of novel N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as the inhibitors of tubulin polymerization in leukemia cells

inferredcites →https://doi.org/10.1016/j.ejphar.2014.05.026openalex-extracted

Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance

inferredcites →https://doi.org/10.1016/j.ejphar.2019.172472openalex-extracted

Alkaloids for cancer prevention and therapy: Current progress and future perspectives

inferredcites →https://doi.org/10.1016/j.ijpharm.2017.05.016openalex-extracted

Paclitaxel: What has been done and the challenges remain ahead

inferredcites →https://doi.org/10.1016/j.tcb.2018.05.001openalex-extracted

Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton

inferredcites →https://doi.org/10.1021/acs.jmedchem.2c02115openalex-extracted

Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site

inferredcites →https://doi.org/10.1021/acs.jmedchem.7b01858openalex-extracted

Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy

inferredcites →https://doi.org/10.1021/jm300564bopenalex-extracted

Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents

inferredcites →https://doi.org/10.1021/jm4016526openalex-extracted

Optimization of 4-( N -Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site

inferredcites →https://doi.org/10.1021/jm801315bopenalex-extracted

Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration

inferredcites →https://doi.org/10.1038/375424a0openalex-extracted

Structure of tubulin at 6.5 Å and location of the taxol-binding site

inferredcites →https://doi.org/10.1038/bjc.1995.138openalex-extracted

The interaction with tubulin of a series of stilbenes based on combretastatin A-4

inferredcites →https://doi.org/10.1038/nature02393openalex-extracted

Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain

inferredcites →https://doi.org/10.1038/nature03566openalex-extracted

Structural basis for the regulation of tubulin by vinblastine

inferredcites →https://doi.org/10.1038/s41580-020-0214-3openalex-extracted

The tubulin code and its role in controlling microtubule properties and functions

inferredcites →https://doi.org/10.1083/jcb.91.2.479openalex-extracted

Taxol binds to polymerized tubulin in vitro

inferredcites →https://doi.org/10.1158/0008-5472.can-06-4018openalex-extracted

Antitumor and Antivascular Effects of AVE8062 in Ovarian Carcinoma

inferredcites →https://doi.org/10.1158/0008-5472.can-07-0127openalex-extracted

MPC-6827: A Small-Molecule Inhibitor of Microtubule Formation That Is Not a Substrate for Multidrug Resistance Pumps

inferredcites →https://doi.org/10.1634/theoncologist.2010-0432openalex-extracted

Cardiovascular Toxicity Profiles of Vascular-Disrupting Agents

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.